Atlas Trials

Effect of Mesenchymal Stem Cells-derived Exosomes in Decompensated Liver Cirrhosis

Clinical trial NCT05871463 · UNKNOWN

Trial details

NCT number
NCT05871463
Sponsor
Research Institute for Gastroenterology and Liver Diseases (RIGLD)
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Decompensated Liver Cirrhosis
Start date
2023-05-26
Primary completion
2023-08-11
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.